Media Kit

Wesper press resources.

Company facts, brand assets, recent coverage and media contacts.

An open Wesper Lab kit

Wesper at a Glance

The facts, ready to cite.

Company

  • Founded in 2017, headquartered in New York
  • Co-founder and CEO: Amir Reuveny, Ph.D.
  • About $13.9M raised, including a $9.6M Series A (2022)
  • Investors include Valor Equity Partners, Breyer Capital and Spark Capital

Products

  • Wesper Lab: FDA-cleared home sleep apnea test with direct respiratory data (K203343)
  • Wesper Lite: FDA-cleared, PPG-based home sleep apnea test, powered by Cassie (K252628)
  • One provider portal, patient record and interpretation pipeline

Proof Points

  • 95%+ AHI correlation to in-lab PSG
  • 99%+ patient success rate (Wesper, Q3 2026)
  • SOC 2 Type 2 and HIPAA compliant
  • TIME Best Inventions of 2026, Special Mention
Wesper is not a wearable. It's a medical-grade diagnostic tool trusted by leading physicians, health systems, and sleep specialists.
Amir Reuveny, Ph.D.Co-Founder & CEO

Common Media Questions

Wesper, in brief.

What is Wesper?

Wesper develops FDA-cleared home sleep testing medical devices. Our multi-tier ecosystem brings together two levels of testing, Wesper Lab and Wesper Lite, with a clinical portal and a managed service for dropship, patient support and optional interpretation.

What problem does Wesper solve?

An estimated 84 million Americans have obstructive sleep apnea, and around 80% are undiagnosed. With roughly one board-certified sleep physician for every 45,000 Americans (AASM; U.S. Census Bureau), the bottleneck is access. Wesper expands home testing so more patients get diagnosed and followed over time.

How is Wesper different?

Wesper is a multi-tier ecosystem. Physicians match the right test to each patient: Wesper Lab for direct respiratory data in complex cases, Wesper Lite for screening and remote monitoring, on one workflow and one patient record.

How does Wesper work?

Providers order a test in the Wesper portal or their EMR. Wesper dropships the kit to the patient, guides them through multi-night testing with 24/7 support, and returns scored studies to the clinic, with optional interpretation by board-certified sleep physicians.

Who can I speak to?

Media requests are handled by our team through the contact form. Our spokesperson is co-founder and CEO Amir Reuveny, Ph.D.

Media Requests

Talk to our team.

Interview requests, press inquiries and speaking opportunities.

Send a media request